Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Treace Medical Concepts, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $246.7K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$246.7K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Treace Medical Concepts, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Treace John T. | Chief Executive Officer | 7,404,383 | Aug 24, 2026 | 8 |
| Scanlan Sean F. | Chief Innovation Officer | 679,863 | Aug 12, 2026 | 5 |
| Hair Mark | Chief Financial Officer | 914,900 | Aug 12, 2026 | 6 |
| Elder Scot Michael | Chief Legl & Comp Off, CorpSec | 778,683 | Aug 12, 2026 | 6 |
| Bakewell John K | Director | 204,056 | May 19, 2026 | 1 |
| Hamilton Lawrence W | Director | 74,056 | May 19, 2026 | 1 |
| Kiernan Jane E | Director | 93,949 | May 19, 2026 | 1 |
| Berry Lance A | Director | 74,593 | May 19, 2026 | 1 |
| Jain Deepti | Director | 100,243 | May 19, 2026 | 1 |
| Hanna Betsy | Director | 75,243 | May 19, 2026 | 1 |
| Guglielmino Guy | Chief Commercial Officer | 490,901 | Jan 23, 2026 | 2 |
| Berutti Aaron | SVP, Sales | 205,092 | Aug 12, 2025 | 0 |
| Mott Richard W | Director | 1,096,861 | May 21, 2025 | 0 |
| Treace James T | Director | 1,223,441 | Aug 19, 2024 | 0 |
| Bays F Barry | Other: Former Director | 0 | Jun 8, 2023 | 0 |
| Timbie Thomas E | Director | 1,149,069Indirect | Mar 17, 2023 | 0 |
| Owens Daniel E. | Other: Chief Human Resources Officer | 30,914 | Mar 17, 2023 | 0 |
| Treace John R | Director | 1,822,790Indirect | May 11, 2022 | 0 |
| Frias Jaime A. | Chief Legal Officer | 50,659 | Mar 10, 2022 | 0 |
| Lubben Terry W. | SVP, Operations | 5,850 | Mar 10, 2022 | 0 |
| Ferguson Joe W. | SVP, Research & Development | 419,756 | Oct 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 (view filing) | Apr 28-May 1 | 4 days | Treace James TDirector | SSale | −50.0K | $25.06 | −$1.25M | −5.5%861.4K after | 3 lots |
| May 18, 2023 (view filing)9:00 PM ET | May 16 | 2 days | Scanlan Sean F.Chief Innovation Officer | SSale | −25.0K | $25.44 | −$636.0K | −43.6%32.4K after | |
| Jun 8, 2023 (view filing) | Jun 2-5 | 6 daysLate | Bays F BarryOther: Former Director | SSale | −1.09M | $26.51 | −$28.9M | −100.0%0 after | 2 lots |
| Mar 29, 2024 (view filing) | Nov 15, 2022 | 500 daysLate | Treace James TDirector | SSale | −50.0K | $20.29 | −$1.01M | −4.6%1.04M after | 4 lots10b5-1 |
| May 13, 2024 (view filing) | May 10-13 | 3 days | Treace John T.Chief Executive Officer | PPurchase | +300.0K | $4.57 | +$1.37M | +5.2%6.09M after | 2 lots |
| May 13, 2024 (view filing) | May 10 | 3 days | Bakewell John KDirector | PPurchase | +130.0K | $4.57 | +$594.1K | +2,575.3%135.0K after | |
| May 13, 2024 (view filing) | May 10-13 | 3 days | Treace James TDirector | PPurchase | +228.0K | $4.54 | +$1.03M | +28.1%1.04M after | 2 lots |
| May 13, 2024 (view filing) | May 10-13 | 3 days | Mott Richard WDirector | PPurchase | +120.0K | $4.51 | +$541.4K | +13.2%1.03M after | 2 lots |
| May 13, 2024 (view filing) | May 10 | 3 days | Jain DeeptiDirector | PPurchase | +25.0K | $4.50 | +$112.5K | +401.0%31.2K after | |
| May 14, 2024 (view filing) | May 14 | Same day | Treace John T.Chief Executive Officer | PPurchase | +150.0K | $5.12 | +$768.0K | +2.5%6.24M after | |
| May 14, 2024 (view filing) | May 14 | Same day | Kiernan Jane EDirector | PPurchase | +19.4K | $5.17 | +$100.1K | +346.6%24.9K after | |
| May 20, 2024 (view filing) | May 17 | 3 days | Treace John T.Chief Executive Officer | PPurchase | +100.0K | $5.56 | +$556.0K | +1.6%6.34M after | |
| May 23, 2024 (view filing) | May 22 | 1 day | Mott Richard WDirector | PPurchase | +12.1K | $4.99 | +$60.4K | +1.2%1.05M after | |
| May 28, 2024 (view filing) | May 24 | 4 days | Mott Richard WDirector | PPurchase | +18.0K | $5.19 | +$93.4K | +1.7%1.07M after | |
| May 29, 2024 (view filing) | May 28 | 1 day | Treace James TDirector | PPurchase | +50.0K | $5.07 | +$253.5K | +4.8%1.09M after | |
| May 30, 2024 (view filing) | May 29 | 1 day | Treace James TDirector | PPurchase | +25.0K | $5.20 | +$130.0K | +2.3%1.11M after | |
| Jun 3, 2024 (view filing) | May 31 | 3 days | Treace James TDirector | PPurchase | +25.0K | $6.05 | +$151.3K | +2.2%1.14M after | |
| Jun 11, 2024 (view filing) | Jun 11 | Same day | Treace John T.Chief Executive Officer | PPurchase | +45.0K | $5.88 | +$264.6K | +0.7%6.39M after | |
| Aug 15, 2024 (view filing) | Aug 14 | 1 day | Treace John T.Chief Executive Officer | PPurchase | +85.0K | $6.00 | +$510.0K | +1.3%6.47M after | |
| Aug 19, 2024 (view filing) | Aug 15 | 4 days | Treace James TDirector | PPurchase | +84.0K | $5.96 | +$500.6K | +7.4%1.22M after | |
| Sep 17, 2024 (view filing) | Sep 16 | 1 day | Treace John T.Chief Executive Officer | PPurchase | +50.0K | $5.31 | +$265.5K | +0.8%6.52M after | |
| Mar 4, 2025 (view filing) | Mar 4 | Same day | Treace John T.Chief Executive Officer | PPurchase | +60.0K | $8.73 | +$523.8K | +0.9%6.80M after | |
| Mar 19, 2025 (view filing) | Mar 17 | 2 days | Scanlan Sean F.Chief Innovation Officer | SSale | −50.0K | $7.97 | −$398.5K | −12.1%364.1K after | 10b5-1 |
| May 14, 2026 (view filing) | May 12-14 | 2 days | Treace John T.Chief Executive Officer | PPurchase | +153.8K | $2.44 | +$375.7K | +2.2%7.16M after | 3 lots |
| May 28, 2026 (view filing) | May 26-28 | 2 days | Treace John T.Chief Executive Officer | PPurchase | +115.5K | $2.95 | +$340.4K | +1.6%7.27M after | 3 lots |
| Jun 1, 2026 (view filing) | Jun 1 | Same day | Treace John T.Chief Executive Officer | PPurchase | +50.0K | $3.56 | +$178.0K | +0.7%7.32M after | |
| Jun 12, 2026 (view filing) | Jun 10-11 | 2 days | Treace John T.Chief Executive Officer | PPurchase | +24.6K | $4.03 | +$99.1K | +0.3%7.35M after | Amended2 lots |
| Aug 24, 2026 (view filing)5:00 PM ET | Aug 20-24 | 4 days | Treace John T.Chief Executive Officer | PPurchase | +55.9K | $4.41 | +$246.7K | +0.8%7.40M after | 3 lots |